| 2001 |
TDP1 belongs to the phospholipase D (PLD) superfamily, containing two HKD signature motifs. Mutagenesis of the invariant histidines and lysines of the HKD motifs confirmed they are essential for TDP1 activity. The reaction proceeds through formation of a covalent enzyme-DNA intermediate (phosphoryl transfer mechanism common to PLD superfamily members). |
Sequence analysis + site-directed mutagenesis of human TDP1 + biochemical activity assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
11572945
|
| 2002 |
Crystal structure of human TDP1 at 1.69 Å resolution reveals a monomer composed of two similar domains related by pseudo-2-fold symmetry, each contributing conserved histidine, lysine, and asparagine residues to form a single active site, confirming PLD superfamily membership and suggesting the catalytic mechanism and substrate binding mode. |
X-ray crystallography |
Structure |
High |
11839309
|
| 2002 |
Crystal structures of human TDP1 bound to phosphate transition state analogs vanadate and tungstate show the inhibitor covalently bound to His263, confirming His263 as the nucleophile in the first catalytic step. Vanadate displays trigonal bipyramidal geometry mimicking the phosphodiester hydrolysis transition state. |
X-ray crystallography with transition state analog inhibitors |
Journal of molecular biology |
High |
12470949
|
| 2002 |
A homozygous mutation (A1478G, H493R) in TDP1 causes SCAN1. His493 is located in the active site; protein modeling predicts disruption of the symmetric active site structure. TDP1 normally repairs covalently bound topoisomerase I-DNA complexes to prevent double-strand breaks during DNA replication. |
Genome-wide linkage mapping, positional cloning, protein modeling |
Nature genetics |
High |
12244316
|
| 2003 |
Crystal structure of a transition state mimic assembled from vanadate, DNA, and a topoisomerase I-derived peptide in a quaternary complex with human TDP1 demonstrates that the topoisomerase I-DNA complex must undergo extensive modification (proteolytic trimming) before cleavage by TDP1. |
X-ray crystallography of quaternary transition state mimic complex |
Chemistry & biology |
High |
12618186
|
| 2003 |
XRCC1 immunoprecipitates contain TDP1 polypeptide and TDP1 activity, establishing a physical and functional interaction between TDP1 and XRCC1. XRCC1-complemented cells repair Top1-induced DNA breaks faster and exhibit enhanced TDP1 and PNKP activities. |
Co-immunoprecipitation, enzymatic activity assays in XRCC1-deficient and complemented cells |
DNA repair |
Medium |
13679147
|
| 2005 |
The SCAN1 H493R mutant TDP1 retains ~4% residual activity but accumulates a covalent TDP1-DNA intermediate with ~13 min half-life. Wild-type TDP1 can remove the stalled H493R mutant from DNA (hydrolyzing phosphohistidine linkages), explaining the recessive nature of SCAN1. TDP1 also possesses limited 3'-exonuclease activity and can remove 3'-abasic sites and 3'-biotin adducts. |
In vitro enzymatic assays with recombinant wild-type and H493R mutant TDP1, SCAN1 patient cell lines |
The Journal of biological chemistry |
High |
16141202
|
| 2005 |
H493R TDP1 (SCAN1 mutant) reduces enzyme activity ~25-fold and causes accumulation of the covalent TDP1-DNA reaction intermediate. SCAN1 patient-derived cell lines are hypersensitive to camptothecin, directly implicating TDP1 in repair of CPT-induced topoisomerase I damage in human cells. |
Biochemical assays with purified proteins, camptothecin sensitivity assays in SCAN1 patient cell lines |
The EMBO journal |
High |
15920477
|
| 2005 |
TDP1 is the primary enzyme responsible for 3'-phosphoglycolate (PG) removal in human cell extracts. Extracts from SCAN1 cells (H493R TDP1) fail to process 3'-PG termini on single-strand oligomers and 3' overhangs of DSBs; activity is restored by addition of recombinant TDP1. |
In vitro end-joining assays with cell extracts from SCAN1 patients and normal controls; complementation with recombinant TDP1 |
Nucleic acids research |
High |
15647511
|
| 2005 |
Human TDP1 prefers single-stranded and blunt-ended duplex substrates over nicked and tailed duplex conformations for 3'-phosphotyrosyl bond hydrolysis, suggesting TDP1 acts primarily at double-strand breaks in vivo. |
Kinetic and binding assays with purified human TDP1 on defined DNA substrates |
The Journal of biological chemistry |
Medium |
15811850
|
| 2006 |
TDP1 participates in repair of topoisomerase II (Top2)-mediated DNA damage in yeast. Deletion of TDP1 confers hypersensitivity to Top2-targeting agents; bacterially expressed yeast TDP1 can remove a Top2-derived peptide covalently linked to DNA via a 5'-phosphotyrosyl linkage in vitro. |
Genetic deletion studies in yeast, in vitro biochemical assay with 5'-phosphotyrosyl substrate |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16751265
|
| 2006 |
SCAN1 cells deficient in TDP1 (H493R) show enhanced levels of Top1 cleavage complexes and defective reversal of Top1cc after camptothecin treatment. The repair defect is not affected by aphidicolin, indicating TDP1 repairs transcription-associated Top1cc independently of replication. |
Top1 cleavage complex assays, camptothecin treatment, aphidicolin inhibition in SCAN1 cells |
DNA repair |
Medium |
16935573
|
| 2007 |
TDP1 is phosphorylated at S81 by ATM and DNA-PK kinases in response to Top1-associated DNA double-strand breaks. S81 phosphorylation stabilizes TDP1 protein, induces formation of XRCC1-TDP1 complexes, and enhances mobilization of TDP1 to DNA damage sites; promotes cell survival and DNA repair. |
Mass spectrometry identification of phosphorylation site, kinase inhibition assays, Co-IP of TDP1-XRCC1, live-cell imaging of TDP1 foci, S81A/S81E mutant analysis |
The EMBO journal |
High |
19851285
|
| 2007 |
TDP1 is required for efficient repair of chromosomal single-strand breaks in neurons. Tdp1-/- mice show age-dependent cerebellar atrophy; cerebellar neurons and astrocytes from Tdp1-/- mice are defective in repair of SSBs from Top1-DNA complexes and oxidative damage. |
Tdp1 knockout mouse generation, in vitro and in vivo SSB repair assays, histology |
The EMBO journal |
High |
17914460
|
| 2007 |
TDP1 is associated with DNA ligase IIIα (Lig3α) and XRCC1 in the single-strand break repair machinery. TDP1 activity at abortive Top1-SSBs is stimulated by XRCC1/Lig3α in vitro. TDP1 is required for repair of ionizing radiation-induced SSBs, partly due to IR-induced protein-DNA cross-links processed by TDP1. |
In vitro TDP1 activity stimulation assay with XRCC1/Lig3α, γH2AX and comet assays in TDP1-deficient SCAN1 cells |
DNA repair |
Medium |
17600775
|
| 2007 |
Tdp1-/- mice are physically, histologically, and electrophysiologically indistinguishable from wild-type but are hypersensitive to CPT and bleomycin (not etoposide). The H493R SCAN1 mutant protein becomes covalently trapped on DNA after CPT treatment in SCAN1 cells, providing direct in vivo demonstration that Tdp1 repairs Top1 covalent lesions and that SCAN1 arises from a recessive neomorphic mutation. |
Tdp1-/- mouse model, drug sensitivity assays, trapping assay in SCAN1 patient cells |
The EMBO journal |
High |
17948061
|
| 2009 |
In fission yeast, Tdp1 and Pnk1 (polynucleotide kinase) process the same naturally occurring 3'-ends produced from oxidative DNA damage in quiescent (G0) cells. Tdp1 function in quiescent cells is independent of topoisomerase I, and mitochondrial respiration causes the DNA damage that Tdp1 repairs. |
Genetic analysis in S. pombe tdp1 and pnk1 mutants, quiescence assays, antioxidant rescue experiments |
The EMBO journal |
Medium |
19197239
|
| 2009 |
TDP1 serine 81 phosphorylation is required for interaction with DNA ligase IIIα; S81A mutation reduces protein stability and cell survival after genotoxic stress without affecting TDP1 catalytic activity or acute repair kinetics in vivo. |
S81A mutant cell lines, Co-IP, clonogenic survival assays, in vitro TDP1 activity assay |
Cell cycle |
Medium |
20009512
|
| 2010 |
TDP1 localizes to mitochondria (demonstrated by laser confocal microscopy, subcellular fractionation, and biochemical analyses). Mitochondrial base excision repair depends on TDP1 activity; TDP1 is required for efficient repair of oxidative damage in mitochondrial DNA. |
Confocal microscopy, subcellular fractionation, mitochondrial BER assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
21041670
|
| 2010 |
Yeast TDP1 functions in non-homologous end joining (NHEJ) by regulating fidelity; tdp1Δ cells show high frequency of 2-4 nucleotide insertions at 5'-extension DSBs via a Ku80- and DNA ligase IV-dependent mechanism. TDP1's 3'-nucleosidase activity is proposed to generate 3'-phosphate ends that restrict polymerase access, preventing insertion errors. |
Yeast genetic deletion, NHEJ reporter assays, analysis of repair junctions |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
20160111
|
| 2012 |
TDP1 repairs a broad spectrum of DNA lesions including Top1cc, Top2cc (processing 5'-phosphotyrosyl ends), 3'-phosphoglycolates, 3'-deoxyribose phosphates, and chain-terminating nucleoside analogs. TDP1-/- DT40 cells are defective in mitochondrial TDP1 activity. TDP1 and CtIP act in parallel pathways for Top1cc/MMS repair but are epistatic for Top2cc. |
TDP1 knockout DT40 cells, in vitro biochemical assays with recombinant human TDP1, dual knockout epistasis analysis |
The Journal of biological chemistry |
High |
22375014
|
| 2012 |
TDP1 is SUMOylated at lysine 111 in mammalian cells. SUMOylation does not affect TDP1 catalytic activity but promotes its accumulation at DNA damage sites. A SUMOylation-deficient TDP1 (K111R) mutant displays reduced repair of chromosomal SSBs arising from transcription-associated Top1 activity or oxidative stress. |
Purification of SUMOylated TDP1 from mammalian cells, mass spectrometry identification of K111, K111R mutant analysis, repair assays |
Nature communications |
High |
22415824
|
| 2013 |
TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating nucleoside analogs (CTNAs: acyclovir, cytarabine, AZT, ddC) by removing covalently linked CTNAs from DNA 3'-ends. Tdp1-/- cells are hypersensitive to ACV and Ara-C and accumulate more DNA damage; AZT and ddC treatment leads to greater mitochondrial DNA depletion in Tdp1-/- cells. |
In vitro TDP1 activity assays with CTNA-terminated substrates, Tdp1-/- DT40 cell sensitivity assays, mitochondrial DNA quantification |
Nucleic acids research |
High |
23775789
|
| 2014 |
PARP1 directly binds TDP1 (N-terminal domain of TDP1 binds C-terminal domain of PARP1) and PARylates TDP1. PARylation stabilizes TDP1 together with SUMOylation and enhances TDP1 recruitment to DNA damage sites without interfering with catalytic activity. TDP1 and PARP1 are epistatic for repair of Top1cc. TDP1-PARP1 complexes recruit XRCC1. |
TDP1/PARP1 double-knockout DT40 cells, Co-IP of TDP1-PARP1, domain mapping, PARylation assays, DNA damage foci assays |
Nucleic acids research |
High |
24493735
|
| 2015 |
TDP1 physically interacts with XLF and promotes assembly of NHEJ protein complexes on DNA. TDP1:XLF:DNA complexes form and XLF binding preferentially stimulates TDP1 activity on dsDNA vs. ssDNA. TDP1 also promotes DNA binding by Ku70/80 and stimulates DNA-PK activity, suggesting a role in early NHEJ. |
Biochemical pulldown assays, DNA-binding assays, kinase activity assays |
DNA repair |
Medium |
25841101
|
| 2017 |
TDP1 is required for efficient NHEJ of cohesive DSBs in human cells. TDP1-KO HEK-293 cells show 5-fold reduced NHEJ repair and increased insertion events. TDP1-XLF interaction is reduced by S81A and abolished by S81E phosphomimetic mutations, linking phosphorylation status to NHEJ regulation. |
CRISPR/Cas9 TDP1 knockout cells, chromosomal NHEJ reporter, cell-free NHEJ assays, junction analysis, S81 phosphorylation mutants |
DNA repair |
High |
29078113
|
| 2018 |
PRMT5 directly binds TDP1 and catalyzes symmetric arginine dimethylation at R361 and R586. R361/R586 methylation enhances TDP1 3'-phosphodiesterase activity, increases XRCC1 association with TDP1, and recruits XRCC1 to Top1cc damage foci. PRMT5 knockdown impairs TDP1 activity and increases CPT-induced DNA damage. |
Co-IP of PRMT5-TDP1, mass spectrometry identification of methylation sites, R361A/R586A mutant analysis, PRMT5 knockdown, DNA damage foci assays, enzymatic activity assays |
Nucleic acids research |
High |
29718323
|
| 2018 |
UCHL3 is the deubiquitylase that controls TDP1 proteostasis. UCHL3 depletion increases TDP1 ubiquitylation and turnover; UCHL3 overexpression (but not catalytically inactive mutant) suppresses TDP1 ubiquitylation. TDP1 overexpression in rhabdomyosarcoma is driven by UCHL3 overexpression; UCHL3 is downregulated in SCAN1, causing elevated TDP1 ubiquitylation and faster turnover. |
UCHL3 depletion/overexpression, ubiquitylation assays, TDP1 turnover assays, catalytically inactive UCHL3 mutant |
Cell reports |
High |
29898404
|
| 2019 |
SCAN1-TDP1 (H493R) is selectively trapped on mitochondrial DNA in regulatory non-coding and promoter regions. Trapped TDP1H493R-mtDNA complexes cause Drp1-mediated mitochondrial fission, block mitobiogenesis, and trigger PINK1-dependent mitophagy to eliminate dysfunctional mitochondria. |
mtDNA-TDP1 trapping assays, mitochondrial morphology imaging, mitophagy assays, mitochondrial-targeted TOP1 poison (mito-SN38) in nanoparticles |
Science advances |
Medium |
31723605
|
| 2022 |
PRMT5-mediated R586 methylation promotes TDP1 ubiquitylation, which facilitates proteasome-dependent TDP1 turnover by impeding UCHL3 (deubiquitylase) binding to TDP1. R361 methylation enhances TDP1 3'-phosphodiesterase activity. These modifications establish mechanistic crosstalk between arginine methylation and ubiquitylation controlling TDP1 homeostasis. |
Arginine methylation-deficient mutants, ubiquitylation assays, UCHL3 binding assays, real-time fluorescence-based TDP1 cleavage assays, structural modeling |
Cell reports |
High |
35705029
|
| 2022 |
Human TDP1 can repair 3'-PUA-protein DPCs (DNA-protein crosslinks arising from abasic sites) in vitro. TDP1 removes 3'-PUA-aminooxylysine-peptide adducts and directly repairs 3'-PUA-histone DPCs but not 3'-PUA-PARP1 DPCs unless proteolysis occurs first. Kinetic constants were determined for multiple substrate configurations. |
Biochemical reconstitution with synthetic 3'-PUA-peptide substrates, kinetic analysis, comparison with APE1 and TREX1 |
Nucleic acids research |
Medium |
35349719
|
| 2022 |
MUS81 is a key factor that mediates generation of excess DSBs in TDP1 KO cells (via CRISPR screens). APEX1/2 are synthetic lethal with TDP1 but APEX1/2 deficiency does not reduce DSB formation in TDP1 KO cells. TOP1cc can be either resolved directly by TDP1 or converted into DSBs repaired by homologous recombination. |
Whole-genome CRISPR screen, co-deficient cell generation, DSB quantification assays |
Nature communications |
Medium |
35869071
|
| 2024 |
SCAN1 (H493R TDP1) cells accumulate TOP1ccs and transcriptional DSBs specifically in G1 phase, due to increased DSB formation from abortive removal of transcription-blocking TOP1ccs. The mutant TDP1 protein actively hampers DSB repair via a TDP2-dependent backup pathway (gain of function), distinct from simple loss of TDP1 activity. |
CRISPR-Cas9 human SCAN1 cell models, TOP1cc assays, DSB quantification in cell cycle phases, R-loop analysis, TDP2-dependent repair assays |
Cell reports |
High |
38761375
|
| 2014 |
Drosophila TDP1 gene glaikit (gkt) encodes the functional ortholog of human TDP1; protein extracts from gkt mutant flies are defective in hydrolyzing 3'-DNA-tyrosyl residues. Loss of gkt causes reduced lifespan, diminished climbing ability, and sensitivity to bleomycin and Top1 poisons; all phenotypes are rescued by neuronal expression of TDP1. |
Drosophila PiggyBac insertion mutant, in vitro TDP1 activity assay in fly extracts, behavioral assays, neuronal rescue experiments |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
25331878
|
| 2009 |
Loss of both TDP1 and aprataxin (APTX) in mouse neural cells synergistically slows global repair of oxidative and alkylation-induced SSBs, but not CPT-induced Top1-SSBs (which accumulate equally in Tdp1-/- and Tdp1-/-/Aptx-/- astrocytes), placing TDP1 and APTX in partially overlapping but distinct SSB repair sub-pathways. |
Tdp1-/-/Aptx-/- double knockout mouse, quantitative SSB repair assays in quiescent astrocytes |
DNA repair |
Medium |
19303373
|
| 2018 |
TDP1 and Artemis are epistatic for repair of 3'-phosphoglycolate-terminated DSBs by classical NHEJ. A TDP1 deficiency (but not Artemis deficiency) results in increased dicentric chromosomes following neocarzinostatin treatment, whereas Artemis deficiency results in unrepaired DSBs (53BP1 foci). TDP1 and Artemis perform distinct functions in C-NHEJ of terminally blocked DSBs. |
TDP1 knockout/knockdown in Artemis-null cells, γH2AX and 53BP1 foci, cytogenetic analysis, DNA-PK inhibitor studies |
Nucleic acids research |
Medium |
30113698
|
| 2017 |
TDP1 suppresses chromosomal translocations arising from TOP1-induced DSBs during gene transcription. These translocations involve the MRN complex and canonical NHEJ. TDP1-dependent end-joining protects gene transcription and genome stability. |
TDP1 mutant/deletion cells, translocation frequency assays, epistasis with MRN and NHEJ factors |
Nature communications |
Medium |
37945566
|
| 2023 |
TDP1 and SPRTN repair endogenous, CPT-induced, and formaldehyde-induced DNA-protein crosslinks including histone H3-DPCs and TOP1-DPCs. Resolution of H3-DNA crosslinks requires upstream proteolysis by SPRTN followed by peptide removal by TDP1 in RPE1 cells and zebrafish embryos. SPRTN and TDP1 function in different pathways for endogenous TOP1-DPCs. TDP2 expression is increased in TDP1-deficient cells/embryos. |
TDP1 and SPRTN knockouts in human cells and zebrafish, DPC quantification with antibodies, TDP2 expression analysis |
Open biology |
Medium |
37788708
|